4 completed. 3 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow BufferGel: new trials by email Literature Review of BufferGel trials Research Report on BufferGel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women BufferGel, PRO 2000/5 Gel, Placebo gel - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 3101 | 2005-01-01 | 2021-11-08 |
| Open Label Study of the Safety and Contraceptive Efficacy of BufferGel® With Diaphragm Drug: BufferGel® with diaphragm - Contraception | Phase 2 / Phase 3 | Completed | ReProtect Inc | 200 | 2004-01-01 | 2006-11-09 |
| Effectiveness of BufferGel as a Vaginal Contraceptive BufferGel - Pregnancy | Phase 2 / Phase 3 | Completed | Premier Research | 975 | 2001-09-01 | 2016-08-19 |
| A Study of BufferGel in Women BufferGel - HIV Infections | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 40 | 2007-01-09 |
HIV Infections (2)
National Institute of Allergy and Infectious Diseases (NIAID) (2) · Premier Research (1) · ReProtect Inc (1)
United States (3) · Malawi (1) · South Africa (1) · Zambia (1) · Zimbabwe (1)
Gita Ramjee, PhD (1) · Groesbeck Parham, MD (1) · H. Trent MacKay, MD, MPH (1) · Irving Hoffman, PA, MPH (1) · Kenneth Mayer (1) · Kenrad Nelson (1) · Lisa Maslankowski, MD (1) · Nancy Padian, PhD (1) · Salim Abdool Karim, MBChB, PhD (1) · Taha Taha, MD (1)
PMID 17453597, PMID 17766603, PMID 20368766, PMID 21330907, PMID 23334506, PMID 24898857